Antipsychotics in dementia: Best Practice Guide

Introduction, Rationale and Key Points   Behavioural and Psychological Symptoms of Dementia (BPSD)   Assessment of patients with BPSD   Non-pharmacological treatment of BPSD   Pharmacological treatment of BPSD   Adverse effects of antipsychotics   Dementia with Lewy Bodies (DLB)   Other medicines for BPSD   Treatment of comorbid conditions in patients with dementia   References   Appendix

---

References.

1. Anon 2008 Always a Last Resort. All Party Parliamentary Group on Dementia, April 2008. Avaialble from: http://www.alzheimers.org.uk/downloads/ALZ_Society_APPG.pdf (accessed 07/08)
2. FDA 2008. US FDA alert: Antipsychotics associated with increased risk of mortality in elderly patients. FDA 17/06/08. Available from; http://www.fda.gov/ (accessed 07/08)
3. International Psychogeriatric Association. BPSD: Introduction to behavioural and psychological symptoms of dementia, 2002. http://www.ipa-online.org
4. yrne GJ. Pharmacological treatment of behavioural problems in dementia. Aust Prescriber 2005;28:67-70
5. SIGN, 2006 Dementia Guidelines. Available from; http://www.sign.ac.uk/pdf/sign86.pdf (accessed July 2008)
6. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002 Sep 25;288(12):1475-83.
7. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000 May;157(5):708-14.
8. Finkel S. Behaviour and psychological signs and symptoms of dementia. Implications for research and treatment. Int Psychogeriatr 1996;8(suppl 3):497-500
9. Opie J, Rosewarne R, O’Connor DW. The efficacy of psychosocial approaches to behaviour disorders in dementia; a systematic literature review. Aust NZ J Psychiatry1999;33:789-99
10. Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci 1997;52(4):159-66.
11. Schneider LS et al. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006;14:191-210
12. NPS (National Prescribing Service), 2007.. The role of antipsychotics in managing BPSD. Prescribing Practice Review 37. Available from; http://www.nps.org.au/ (accessed July 2008)
13. NICE Dementia Guidelines 2006. Available from; http://www.nice.org.uk/cg42 (accessed July 2008)
14. Ballard CG et al. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry 2004;65:114-9
15. Fossey J et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.BMJ 2006;332:756-61
16. MEREC, 2007. The treatment of dementia. National Prescribing Centre (UK). Available from; http://www.npc.co.uk/ebt/merec/cns/dementia/merec_bulletin_vol18_no1_main.html (accessed July 2008)
17. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43
18. McKeith I et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19-28
19. Glass J et al. Sedative hypnotics in older people with insomnia; meta-analysis of risks and benefits. BMJ 2005;331:1169

Page  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11

Page 10

Submit a comment about this article